Research programme: influenza monoclonal antibodies - Genentech
Latest Information Update: 16 Jul 2016
At a glance
- Originator Dana-Farber Cancer Institute; Sanford-Burnham Medical Research Institute
- Developer Genentech
- Class Monoclonal antibodies
- Mechanism of Action Viral haemagglutinin modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza A virus infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Influenza-A-virus-infections in USA (Parenteral)
- 16 Jul 2016 No recent reports of development identified for research development in Influenza-A-virus-infections(Prevention) in USA (Parenteral)
- 22 Feb 2010 Early research in Influenza A virus infections (treatment and prevention) in USA (Parenteral)